Effects of brain-derived neurotrophic factor (BDNF) on the cochlear nucleus in cats deafened as neonates

被引:4
作者
Kandathil, Cherian K. [1 ,2 ]
Stakhovskaya, Olga [1 ,3 ]
Leake, Patricia A. [1 ]
机构
[1] Univ Calif San Francisco, Epstein Lab, Dept Otolaryngol Head & Neck Surg, 533 Parnassus Ave,Room U490, San Francisco, CA 94143 USA
[2] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Palo Alto, CA 94305 USA
[3] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA
基金
美国国家卫生研究院;
关键词
Neonatal deafness; Aminoglycoside ototoxicity; BDNF; Neurotrophic effects; Cochlear nucleus; SPIRAL-GANGLION NEURONS; AUDITORY NEURONS; ELECTRICAL-STIMULATION; DRUG-DELIVERY; INNER-EAR; SURVIVAL; NT-3; EXPRESSION; CELL; THERAPY;
D O I
10.1016/j.heares.2016.10.011
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Many previous studies have shown significant neurotrophic effects of intracochlear delivery of BDNF in preventing degeneration of cochlear spiral ganglion (SG) neurons after deafness in rodents and our laboratory has shown similar results in developing cats deafened prior to hearing onset. This study examined the morphology of the cochlear nucleus (CN) in a group of neonatally deafened cats from a previous study in which infusion of BDNF elicited a significant improvement in survival of the SG neurons. Five cats were deafened by systemic injections of neomycin sulfate (60 mg/Kg, SQ SID) starting one day after birth, and continuing for 16-18 days until auditory brainstem response (ABR) testing demonstrated profound bilateral hearing loss. The animals were implanted unilaterally at about 1 month of age using custom-designed electrodes with a drug-delivery cannula connected to an osmotic pump. BDNF (94 mu g/ml; 0.25 mu l/hr) was delivered for 10 weeks. The animals were euthanized and studied at 14-23 weeks of age. Consistent with the neurotrophic effects of BDNF on SG survival, the total CN volume in these animals was significantly larger on the BDNF-treated side than on the contralateral side. However, total CN volume, both ipsi- and contralateral to the implants in these deafened juvenile animals, was markedly smaller than the CN in normal adult animals, reflecting the severe effects of deafness on the central auditory system during development. Data from the individual major CN subdivisions (DCN, Dorsal Cochlear Nucleus; PVCN, Posteroventral Cochlear Nucleus; AVCN, Anteroventral Cochlear Nucleus) also were analyzed. A significant difference was observed between the BDNF-treated and control sides only in the AVCN. Measurements of the cross-sectional areas of spherical cells showed that cells were significantly larger in the AVCN ipsilateral to the implant than on the contralateral side. Further, the numerical density of spherical cells was significantly lower in the AVCN ipsilateral to the implant than on the contralateral side, consistent with the larger AVCN volume observed with BDNF treatment. Together, findings indicate significant neurotrophic effects of intracochlear BDNF infusion on the developing CN. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:134 / 143
页数:10
相关论文
共 73 条
[1]   Morphological changes in spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs [J].
Agterberg, Martijn J. H. ;
Versnel, Huib ;
de Groot, John C. M. J. ;
Smoorenburg, Guido F. ;
Albers, Frans W. J. ;
Klis, Sjaak F. L. .
HEARING RESEARCH, 2008, 244 (1-2) :25-34
[2]   Enhanced Survival of Spiral Ganglion Cells After Cessation of Treatment with Brain-Derived Neurotrophic Factor in Deafened Guinea Pigs [J].
Agterberg, Martijn J. H. ;
Versnel, Huib ;
van Dijk, Lotte M. ;
de Groot, John C. M. J. ;
Klis, Sjaak F. L. .
JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY, 2009, 10 (03) :355-367
[3]   Magnetic Beads Enhance Adhesion of NIH 3T3 Fibroblasts: A Proof-of-Principle In Vitro Study for Implant-Mediated Long-Term Drug Delivery to the Inner Ear [J].
Aliuos, Pooyan ;
Schulze, Jennifer ;
Schomaker, Markus ;
Reuter, Guenter ;
Stolle, Stefan R. O. ;
Werner, Darja ;
Ripken, Tammo ;
Lenarz, Thomas ;
Warnecke, Athanasia .
PLOS ONE, 2016, 11 (02)
[4]  
Anson BJ., 1981, EAR DEV ANATOMY SURG, P23
[5]   The role of intracochlear drug delivery devices in the management of inner ear disease [J].
Ayoob, Andrew M. ;
Borenstein, Jeffrey T. .
EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (03) :465-479
[6]  
Bianchi LM, 1996, DEVELOPMENT, V122, P1965
[7]   The use of Neurotrophin Therapy in the Inner Ear to Augment Cochlear Implantation Outcomes [J].
Budenz, Cameron L. ;
Pfingst, Bryan E. ;
Raphael, Yehoash .
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2012, 295 (11) :1896-1908
[8]   Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons [J].
Chikar, Jennifer A. ;
Colesa, Deborah J. ;
Swiderski, Donald L. ;
Di Polo, Adriana ;
Raphael, Yehoash ;
Pfingst, Bryan E. .
HEARING RESEARCH, 2008, 245 (1-2) :24-34
[9]   Gradients of neurotrophins, ion channels, and tuning in the cochlea [J].
Davis, RL .
NEUROSCIENTIST, 2003, 9 (05) :311-316
[10]   Recent advances in local drug delivery to the inner ear [J].
El Kechai, Naila ;
Agnely, Florence ;
Mamelle, Elisabeth ;
Nguyen, Yann ;
Ferrary, Evelyne ;
Bochot, Amelie .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 494 (01) :83-101